Meeting
2020 ASCO Virtual Scientific Program
Enrichment of alterations in targetable molecular pathways in KRAS wild-type (WT) pancreatic cancer (PC).
Authors
Philip Agop Philip
Karmanos Cancer Institute, Detroit, MI
Philip Agop Philip , Joanne Xiu , Michael J. Hall , Andrew Eugene Hendifar , Emil Lou , Jimmy J. Hwang , Jun Gong , Moh'd M. Khushman , Davendra Sohal , A. Craig Lockhart , Benjamin Adam Weinberg , John Marshall , Axel Grothey , Anthony Frank Shields , Wolfgang Michael Korn
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Pancreatic Cancer
Citation
J Clin Oncol 38: 2020 (suppl; abstr 4629)
DOI
10.1200/JCO.2020.38.15_suppl.4629
Abstract #
4629
Poster Bd #
237
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Molecular characterization of NF1-mutated NSCLC and clinical outcomes.
First Author: Christopher Gates
Poster
2018 ASCO Annual Meeting
Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.
First Author: Razelle Kurzrock
Poster
2014 Gastrointestinal Cancers Symposium
Next-generation sequencing in pancreatic cancer: Revealing genomic mutations beyond KRAS.
First Author: Andrea S. Teague
Poster
2016 ASCO Annual Meeting
Comparative molecular analyses of pancreatic cancer (PC): KRAS wild type vs. KRAS mutant tumors and primary tumors vs. distant metastases.
First Author: Mohamed E. Salem